Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SunWay Biotech CoROCO:1271 -4.39%90 Gross Margin % is 53.81% as of Dec. 2025, which is 5% below its 10-year median of 56.43. GuruFocus rates ROCO:1271 with a GF Score™ of 90/100 and a GF Value™ of NT$71.11 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,906 Consumer Packaged Goods companies, SunWay Biotech Co ranks better than 88.67% on this metric.
SunWay Biotech Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -3.8%.
The historical rank and industry rank for SunWay Biotech Co's Gross Margin % or its related term are showing as below:
ROCO:1271'
s Gross Margin % Range Over the Past 10 Years
Min: 35.24 Med: 56.43 Max: 71.26
Current: 56.43
During the past 7 years, the highestGross Margin % of SunWay Biotech Co was 71.26%. The lowest was 35.24%. And the median was 56.43%.
ROCO:1271's Gross Margin % is ranked better than 88.67% of 1906
companies
in the Consumer Packaged Goods industry
Industry Median: 26.355
vs ROCO:1271: 56.43
SunWay Biotech Co had a gross margin of 53.81% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for SunWay Biotech Co was -3.80% per year.
SunWay Biotech Co (ROCO:1271) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
SunWay Biotech Co had a gross margin of 53.81% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
SunWay Biotech Co Gross Margin % Related Terms
SunWay Biotech Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for SunWay Biotech Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, SunWay Biotech Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SunWay Biotech Co Gross Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, SunWay Biotech Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where SunWay Biotech Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
SunWay Biotech Co (ROCO:1271) has a Gross Margin % of 53.81% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on SunWay Biotech Co and its competitors. This is near median its historical median of 56.43. Over the past decade, SunWay Biotech Co's Gross Margin % has ranged from 35.24 to 71.26. According to the industry distribution chart, SunWay Biotech Co ranks #216 out of 1906 companies in the Consumer Packaged Goods industry, placing it in the top 11.3%.
Is SunWay Biotech Co's Gross Margin % too high?
SunWay Biotech Co's current Gross Margin % of 53.81% is near median its 10-year median of 56.43. Over the past 10 years, this metric has ranged from a low of 35.24 to a high of 71.26. The Consumer Packaged Goods industry median Gross Margin % is 26.36. SunWay Biotech Co's value of 53.81% is 104.2% above this industry median. Based on the distribution chart, SunWay Biotech Co ranks #216 out of 1906 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, SunWay Biotech Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SunWay Biotech Co's Gross Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, SunWay Biotech Co ranks #216 out of 1906 companies for Gross Margin %. This places SunWay Biotech Co in the top 11% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 26.36. SunWay Biotech Co's value of 53.81% is 104.2% above this benchmark. Historically, SunWay Biotech Co's own Gross Margin % has ranged from 35.24 to 71.26 over the past decade. While the company's 10-year median is 56.43 vs. the industry median of 26.36, SunWay Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Consumer Packaged Goods company?
The median Gross Margin % among Consumer Packaged Goods companies is 26.36, based on 1,906 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SunWay Biotech Co's current Gross Margin % of 53.81% is 104.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on SunWay Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median Gross Margin % is 26.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SunWay Biotech Co's current Gross Margin % is 53.81%, which is near median its own 10-year median of 56.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SunWay Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, SunWay Biotech Co (ROCO:1271) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$71.11, compared to a current price of NT$61.00 — trading 14.2% below its estimated fair value. The current Gross Margin % is 53.81%, which is near median its 10-year median of 56.43 and 104.2% above the Consumer Packaged Goods industry median of 26.36. SunWay Biotech Co's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For SunWay Biotech Co (ROCO:1271), the current Gross Margin % is 53.81% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SunWay Biotech Co (ROCO:1271) Overvalued in 2026?
Based on GuruFocus' analysis, SunWay Biotech Co stock appears to be undervalued.
The current stock price of NT$61.00 is trading 14.2% below its estimated GF Value™ of NT$71.11.
GuruFocus considers SunWay Biotech Co to be Modestly Undervalued.
Key valuation signals for ROCO:1271:
Gross Margin %: 53.81% (near median its 10-year median of 56.43)
GF Value™: NT$71.11 vs. price of NT$61.00 (14.2% below fair value)
Industry Position: 104.2% above the Consumer Packaged Goods median (#216 of 1906)
No single metric tells the full story. See the ROCO:1271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SunWay Biotech Co Ltd is engaged in the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp, paracasei NTU 101, and the related products.
90GF Score
Get the complete analysis for ROCO:1271
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1271 has been successfully added to your 
